Phase 2 × Unknown × Carcinoma, Ovarian Epithelial × Clear all A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure
Phase 2 Unknown
15 enrolled
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer
Phase 2 Unknown
34 enrolled
Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy
Phase 2 Unknown
110 enrolled
Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer
Phase 2 Unknown
96 enrolled
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
Phase 2 Unknown
20 enrolled
BOLD
Phase 2 Unknown
74 enrolled
Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer
Phase 2 Unknown
20 enrolled
Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer
Phase 2 Unknown
35 enrolled
Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC
Phase 2 Unknown
126 enrolled
A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Phase 2 Unknown
46 enrolled
CLIO
Phase 2 Unknown
160 enrolled
Cell-free DNA Methylation for Epithelial Ovarian Cancer
Phase 2 Unknown
400 enrolled
ANLOLA
Phase 2 Unknown
68 enrolled
68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings
Phase 2 Unknown
30 enrolled
Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma
Phase 2 Unknown
30 enrolled
Total/Subtotal Colectomy in Ovarian Cancer
Phase 2 Unknown
80 enrolled
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Phase 2 Unknown
100 enrolled
Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 2 Unknown
40 enrolled
Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer
Phase 2 Unknown
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
Phase 2 Unknown
400 enrolled
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
Phase 2 Unknown
102 enrolled
Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Phase 2 Unknown
Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
Phase 2 Unknown
Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
Phase 2 Unknown
40 enrolled
Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
Phase 2 Unknown
Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Phase 2 Unknown
88 enrolled
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Phase 2 Unknown
60 enrolled
Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
Phase 2 Unknown
154 enrolled
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
Phase 2 Unknown
200 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
Phase 2 Unknown
100 enrolled
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
Phase 2 Unknown
120 enrolled
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer
Phase 2 Unknown
34 enrolled
Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
Phase 2 Unknown
67 enrolled